Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer
Clinical trial NCT07714447 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07714447
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-30
- Primary completion
- 2029-02-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.